Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chondroma × regorafenib × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 58 Carcinoma, Hepatocellular 20 Neoplasm Metastasis 14 Rectal Neoplasms 9 Colonic Neoplasms 8 Gastrointestinal Stromal Tumors 7 Sarcoma 5 Ovarian Neoplasms 5 Glioblastoma 5 Stomach Neoplasms 4 Osteosarcoma 4 Melanoma 4 Pancreatic Neoplasms 3 Liver Neoplasms 3 Leukemia, Myeloid, Acute 3 Esophageal Neoplasms 3 Colorectal Cancer Metastatic 3 Cholangiocarcinoma 3 Carcinoma, Non-Small-Cell Lung 3 Thyroid Neoplasms 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Gallbladder Neoplasms 2 Fatigue 2

Interventions

regorafenib 1 Curettage 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02389244 2025-09-16

REGOBONE

UNICANCER

Phase 2 Active not recruiting

Chondroma, Chondrosarcoma, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡